| Antitrust and Competition Antitrust and Competition
| Expert Commentary Expert Commentary
May 7, 2021

Waiving IP Protection for COVID Vaccines Is Anti-Innovation and Anti–Public Health

Patent rights were key to the unprecedentedly rapid development and rollout of COVID-19 vaccines.

By

Alden Abbott

Read more at National Review.